Literature DB >> 36267690

Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives.

Guangmin Wei1, Yinghao Pan2, Jingying Wang2, Xia Xiong2, Yuanmin He2, Jixiang Xu2.   

Abstract

Vitiligo is a chronic depigmenting disorder of the skin and mucosa caused by the destruction of epidermal melanocytes. Although the exact mechanism has not been elucidated, studies have shown that oxidative stress plays an important role in the pathogenesis of vitiligo. High mobility group box protein B1 (HMGB1) is a major nonhistone protein and an extracellular proinflammatory or chemotactic molecule that is actively secreted or passively released by necrotic cells. Recent data showed that HMGB1 is overexpressed in both blood and lesional specimens from vitiligo patients. Moreover, oxidative stress triggers the release of HMGB1 from keratinocytes and melanocytes, indicating that HMGB1 may participate in the pathological process of vitiligo. Overall, this review mainly focuses on the role of HMGB1 in the potential mechanisms underlying vitiligo depigmentation under oxidative stress. In this review, we hope to provide new insights into vitiligo pathogenesis and treatment strategies.
© 2022 Wei et al.

Entities:  

Keywords:  HMGB1; melanocytes; oxidative stress; vitiligo

Year:  2022        PMID: 36267690      PMCID: PMC9576603          DOI: 10.2147/CCID.S381432

Source DB:  PubMed          Journal:  Clin Cosmet Investig Dermatol        ISSN: 1178-7015


  81 in total

1.  Hemin Reduces HMGB1 Release by UVB in an AMPK/HO-1-dependent Pathway in Human Keratinocytes HaCaT Cells.

Authors:  Eun Jung Park; Young Min Kim; Ki Churl Chang
Journal:  Arch Med Res       Date:  2017-10-28       Impact factor: 2.235

2.  Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1β, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death.

Authors:  Yusuke Toki; Takato Takenouchi; Hitoshi Harada; Sei-ichi Tanuma; Hiroshi Kitani; Shuji Kojima; Mitsutoshi Tsukimoto
Journal:  Biochem Biophys Res Commun       Date:  2015-02-11       Impact factor: 3.575

Review 3.  The Beclin 1 network regulates autophagy and apoptosis.

Authors:  R Kang; H J Zeh; M T Lotze; D Tang
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

4.  The HMGB1‑IL‑17A axis contributes to hypoxia/reoxygenation injury via regulation of cardiomyocyte apoptosis and autophagy.

Authors:  Xiaorong Hu; Kai Zhang; Zhiqiang Chen; Hong Jiang; Weipan Xu
Journal:  Mol Med Rep       Date:  2017-10-20       Impact factor: 2.952

5.  High Mobility Group B-1 (HMGB-1) Promotes Apoptosis of Macrophage-Derived Foam Cells by Inducing Endoplasmic Reticulum Stress.

Authors:  Han Wu; Zheng Chen; Jian-Zhou Chen; Li-Gang Pei; Jun Xie; Zhong-Hai Wei; Li-Na Kang; Lian Wang; Biao Xu
Journal:  Cell Physiol Biochem       Date:  2018-07-24

Review 6.  Controversial issues in vitiligo patients: a review of old and recent treatments.

Authors:  Torello Lotti; Serena Gianfaldoni; Yan Valle; Miriam Rovesti; Claudio Feliciano; Francesca Satolli
Journal:  Dermatol Ther       Date:  2018-10-21       Impact factor: 2.851

7.  Decreased Circulating T Regulatory Cells in Egyptian Patients with Nonsegmental Vitiligo: Correlation with Disease Activity.

Authors:  Doaa Salah Hegab; Mohamed Attia Saad Attia
Journal:  Dermatol Res Pract       Date:  2015-12-15

8.  Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population.

Authors:  Nasrin Hamidizadeh; Sara Ranjbar; Ahmad Ghanizadeh; Mohammad Mahdi Parvizi; Peyman Jafari; Farhad Handjani
Journal:  Health Qual Life Outcomes       Date:  2020-02-03       Impact factor: 3.186

Review 9.  Melanocytes as instigators and victims of oxidative stress.

Authors:  Laurence Denat; Ana L Kadekaro; Laurent Marrot; Sancy A Leachman; Zalfa A Abdel-Malek
Journal:  J Invest Dermatol       Date:  2014-02-27       Impact factor: 8.551

Review 10.  Targeting Inflammation Driven by HMGB1.

Authors:  Huan Yang; Haichao Wang; Ulf Andersson
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.